Clinical Trial: Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07187011) titled 'Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans' on Sept. 15.

Brief Summary: The purpose of this study is to test the drug PT150, which blocks glucocorticoid receptor (GR) signaling, for treatment of PTSD in Veterans, and establish a safety and efficacy profile that will inform the design of future studies.

Study Start Date: April 01, 2026

Study Type: INTERVENTIONAL

Condition: PTSD - Post Traumatic Stress Disorder

Intervention: DRUG: PT150

Glucorticoid antagonist 900 mg

DRUG: Placebo

900 mg

Recruitment Status: NOT_YET_RECRUITING

Sponsor: San Diego Veterans Healthcare System

Information prov...